RELATED STUDY

Phytocannabinoids in Neurological Diseases: Could They Restore a Physiological GABAergic Transmission?

Key Findings:  Endocannabinoids and phytocannabinoids (e.g. THC, CBD) and their interaction capacity to modulate GABA type A receptor function makes them a novel class of compounds of interest for a wide range of patient populations with various neurological conditions.